Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long‐acting dual amylin and calcitonin receptor agonist improves insulin‐mediated glycaemic control and controls body weight.
Saved in:
| Title: | Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long‐acting dual amylin and calcitonin receptor agonist improves insulin‐mediated glycaemic control and controls body weight. |
|---|---|
| Authors: | Melander, Simone Anna1 (AUTHOR) sme@nordicbio.com, Larsen, Anna Thorsø1 (AUTHOR), Karsdal, Morten Asser1,2 (AUTHOR), Henriksen, Kim1,2 (AUTHOR) |
| Source: | British Journal of Pharmacology. Jun2024, Vol. 181 Issue 12, p1829-1842. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 00071188 |
|---|---|
| DOI: | 10.1111/bph.16329 |
